CAV1 and multiminicore myopathy: Furthermore, by functioning as loss-of-function mutations, they may increase the level of Cav-1 phosphorylation, thereby disrupting the normal RNF213 control of NO bioavailability and contributing to changes in vascular tone and the development of arterial stenosis and ischemic events found in MMD patients.